Graf Akcie COLL (Collegium Pharmaceutical Inc). Diskuze k akciím COLL. Aktuální informace COLL.

Základní informace o společnosti Collegium Pharmaceutical Inc (Akcie COLL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 732.8M
Hodnota podniku (EV) 772.29M
Tržby 326.11M
EBITDA 139.403M
Zisk 106.749M
Růst v tržbách Q/Q 6.26 %
Růst v tržbách Y/Y 8.09 %
P/E (Cena vůči ziskům) 6.83
Forward P/E N/A
EV/Sales 2.37
EV/EBITDA 5.54
EV/EBIT 10.69
PEG 12.07
Price/Sales 2.25
P/FCF 7.20
Price/Book 3.94
Účetní hodnota na akcii 5.27
Hotovost na akcii 5.00
FCF vůči ceně 13.90 %
Počet zaměstnanců 234
Tržba na zaměstnance 1394000
Profit margin 8.63 %
Operating margin 22.15 %
Gross margin 58.01 %
EBIT margin 22.15 %
EBITDA margin 42.75 %
EPS - Zisk na akcii 3.04
EPS - Kvartální růst 260.87 %
EPS - Očekávaný růst příští rok 200.00 %
Return on assets 16.13 %
Return on equity 54.62 %
ROIC 11.89 %
ROCE 14.84 %
Dluhy/Equity 2.46
Čistý dluh/EBITDA 2.76
Current ratio 1.40
Quick Ratio 1.32
Volatilita 2.93
Beta 0.71
RSI 56.62
Cílová cena analytiků 28
Známka akcie (dle analytiků) N/A
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 35.564M
Procento shortovaných akcií 13.99 %
Short ratio 7.73 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie COLL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$296.701$280.413$28.476$1.711---
Cost Of Goods Sold$193.66$165.677$2.595$0.213---
Gross Profit$103.041$114.736$25.881$1.498---
Research And Development Expenses$10.34$8.661$8.572$14.948$7.975$14.959$14.157
SG&A Expenses$116.449$126.76$92.756$80.632$18.932$2.706$1.885
Other Operating Income Or Expenses-------
Operating Expenses$320.449$301.098$103.923$95.793$26.907$17.665$16.042
Operating Income$-23.748$-20.685$-75.447$-94.082$-26.907$-17.665$-16.042
Total Non-Operating Income/Expense$1.026$-18.443$0.582$-0.094$-0.348$-0.252$-0.155
Pre-Tax Income$-22.722$-39.128$-74.865$-94.176$-27.255$-17.917$-16.197
Income Taxes-------
Income After Taxes$-22.722$-39.128$-74.865$-94.176$-27.255$-17.917$-16.197
Other Income-------
Income From Continuous Operations$-22.722$-39.128$-74.865$-94.176$-27.255$-17.917$-16.197
Income From Discontinued Operations-------
Net Income$-22.722$-39.128$-74.865$-94.176$-20.021$-21.217$-6.883
EBITDA$-8.265$90.223$-74.853$-93.427$-26.736$-17.478$-15.873
EBIT$-23.748$-20.685$-75.447$-94.082$-26.907$-17.665$-16.042
Basic Shares Outstanding333330241412
Shares Outstanding333330241412
Basic EPS$-0.68$-1.19$-2.47$-3.88$-1.48$-22.72$-4.06
EPS - Earnings Per Share$-0.68$-1.19$-2.47$-3.88$-1.48$-22.72$-4.06
# 2020 2019 2018 2017 2016 2015
Current Ratio1.26741.25584.23926.195311.48990.4316
Long-term Debt / Capital0.08060.0972-0.01080.0465-1.2552
Debt/Equity Ratio0.13150.12560.01420.03070.0801-1.0626
Gross Margin34.728940.916890.887187.5511--
Operating Margin-8.004-7.3766-264.9494-5498.656--
EBIT Margin-8.004-7.3766-264.9494-5498.656--
EBITDA Margin-2.785632.1751-262.8634-5460.375--
Pre-Tax Profit Margin-7.6582-13.9537-262.9056-5504.15--
Net Profit Margin-7.6582-13.9537-262.9056-5504.15--
Asset Turnover0.96870.96280.210.0106--
Inventory Turnover Ratio20.08321.19451.43130.1619--
Receiveable Turnover4.0673.59752.85650.8037--
Days Sales In Receivables89.7464101.4585127.7808454.1701--
ROE - Return On Equity-25.9882-42.7232-71.9303-69.8076-32.037620.0531
Return On Tangible Equity-39.2239-82.6706-71.9302-70.913-32.0376146.3688
ROA - Return On Assets-7.4182-13.4347-55.2232-58.1272-27.8915-352.0039
ROI - Return On Investment-23.893-38.5714-71.9302-69.0506-30.5488330.0847
Book Value Per Share2.5962.75313.1764.59434.102-0.6211
Operating Cash Flow Per Share-4.30977.35460.8789-1.500717.6226-9.4745
Free Cash Flow Per Share-4.3367.22110.8659-1.493717.6045-9.3617